Episode

388: The FDA's refusal to review Moderna's mRNA flu vaccine

Podcast
The Readout Loud
Published
Feb 12, 2026
Duration seconds
3084
Processing state
not_requested
Canonical source
https://traffic.megaphone.fm/TTSAA7598338376.mp3?updated=1771001918
Audio
https://traffic.megaphone.fm/TTSAA7598338376.mp3?updated=1771001918
JSON
/v1/public/podcasts/the-readout-loud-1134305/episodes/388-the-fda-s-refusal-to-review-moderna-s-mrna-flu-vaccine
Markdown
/podcast/the-readout-loud-1134305/388-the-fda-s-refusal-to-review-moderna-s-mrna-flu-vaccine.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/388-the-fda-s-refusal-to-review-moderna-s-mrna-flu-vaccine/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-readout-loud-1134305/388-the-fda-s-refusal-to-review-moderna-s-mrna-flu-vaccine.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

We’re devoting our entire episode this week to one controversial and impactful topic: the FDA’s decision to block the review of Moderna’s mRNA flu shot. STAT was the first to report that Vinay Prasad, the agency’s top regulator of vaccines, overruled the head of the FDA’s vaccine office and other staffers in making that decision. Prasad’s unilateral action has renewed concerns about the FDA’s regulatory posture under the Trump administration. To help us dig deeply into this important story and its ramifications, we bring on STAT reporters Lizzy Lawrence and Matthew Herper. We also chat with Moderna President Stephen Hoge and former FDA official Jesse Goodman.